Swiss agree to extradite Chinese researcher in US corporate espionage case
The case has exacerbated global fears that China is using networks of highly trained nationals abroad to gain trade secrets,
swissinfo.ch
This content was published on
2 minutes
The Swiss Federal Office of Justice (FOJ)External link has approved the extradition of a Chinese researcher to the United States. Gongda Xue is charged with using trade secrets stolen from a factory of the British pharmaceutical group GlaxoSmithKline (GSK).
The decision was taken on July 12, from which date the researcher has 30 days to appeal to the Federal Criminal Court, a spokeswoman for the FOJ told the French news agency, AFP, on Tuesday.
Gongda Xue is the brother of Yu Xue, a Chinese-American biochemist who pleaded guilty last year at a US District Court in Pennsylvania to stealing trade secrets on GSK’s work in the biopharmaceutical sector, including the treatment of cancer and other serious diseases.
A total of five people were charged in the case, three of whom formed a company in China called Renopharma to sell the stolen trade secrets.
Yu Xue, who worked for GSK from 2006 to 2016, had been presented by the American courts as one of the “leading protein biochemists in the world”.
According to a spokeswoman for the Friedrich Miescher Institute for Biomedical Research, Gongda Xue worked there “as a postdoctoral fellow from 2008 to 2014”.
The US Department of Justice last year called the case an “economic war”, claiming that Renopharma, based in Nanjing, China, is “financed by the Chinese government”.
Related Stories
Popular Stories
More
How ‘nearshoring’ is driving Swiss companies to move to Mexico
Swiss disappointed by failed plastics agreement in Geneva
This content was published on
Switzerland will not get its Geneva agreement against plastic pollution. Chief negotiator Felix Wertli spoke on Friday morning of his delegation's disappointment.
Swiss study examines why women and men choose different professions
This content was published on
According to a new study, the fact that there are still prevalently female and male professions is down to the nature of the job.
Swiss president unveils new theme park dedicated to Saint Bernards
This content was published on
The new Barryland theme park in Martigny, south-western Switzerland, was officially opened on Thursday in the presence of Swiss President Karin Keller-Sutter.
Swiss court rejects diplomats’ daughter’s request for permanent residence
This content was published on
The 17-year-old daughter of a diplomatic couple working in Switzerland is not entitled to a residence permit, the Federal Administrative Court has ruled.
Swiss hospitals urge faster recognition of foreign medical qualifications
This content was published on
Foreign doctors wishing to work in a Swiss hospital have to wait several months for their diplomas to be recognised, a situation the hospital association H+ calls 'untenable'.
Switzerland to introduce code of conduct for collecting referendum signatures
This content was published on
Commercial collectors of signatures for initiatives and referendums could be given a legally non-binding code of conduct. This proposal comes from the Federal Chancellery following the discovery of thousands of falsified signatures.
Priest in Switzerland accused of sexually assaulting minors
This content was published on
The trial of a priest accused of sexually abusing nine people opened on Thursday in the Ticino cantonal criminal court in Lugano, southern Switzerland.
Two out of three people in Switzerland use more than one language daily
This content was published on
Two out of three people in Switzerland regularly use several languages in their everyday lives, most often the country's national languages.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss firms in record number of mergers and acquisitions
This content was published on
The number of merger and acquisition deals involving Swiss companies hit a record high in 2018, according to a report by consultancy firm KPMG.
This content was published on
In recent days, Johnson & Johnson has been urged to review its sprawling portfolio that ranges from baby oil to cancer drugs, and there were questions for Novartis over the future of its struggling eyecare business. This week, Pfizer will update shareholders on plans for a potential break-up, while GlaxoSmithKline is likely to be pressed…
Chinese researcher in ‘economic warfare’ case loses appeal
This content was published on
A Chinese scientist, accused by the US of helping to steal trade secrets, must remain in Swiss custody due to flight risk, says a federal court.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.